Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for prevention of nausea and vomiting in discectomy under spinal anesthesia
IRCT20160307026950N35Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Nausea and vomiting due to dexmedetomidine injection. Started Jun 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20160307026950N35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N35.